Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Neurosci Lett ; 818: 137519, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-37852528

ABSTRACT

Repeated exposure to psychosocial stress modulates the endocannabinoid system, particularly anandamide (AEA) signaling in brain regions associated with emotional distress. The mTOR protein regulates various neuroplastic processes in the brain disrupted by stress, including adult hippocampal neurogenesis. This kinase has been implicated in multiple effects of cannabinoid drugs and the anti-stress behavioral effects of psychoactive drugs. Therefore, our hypothesis is that enhancing AEA signaling via pharmacological inhibition of the fatty acid amide hydrolase (FAAH) enzyme induces an anti-stress behavioral effect through an mTOR-dependent mechanism. To test this hypothesis, male C57Bl6 mice were exposed to social defeat stress (SDS) for 7 days and received daily treatment with either vehicle or different doses of the FAAH inhibitor, URB597 (0.1; 0.3; 1 mg/Kg), alone or combined with rapamycin. The results suggested that URB597 induced an inverted U-shaped dose-response curve in mice subjected to SDS (with the intermediate dose of 0.3 mg/kg being anxiolytic, and the higher tested dose of 1 mg/Kg being anxiogenic). In a second independent experiment, rapamycin treatment induced an anxiogenic-like response in control mice. However, in the presence of rapamycin, the anxiolytic dose of URB597 treatment failed to reduce stress-induced anxiety behaviors in mice. SDS exposure altered the hippocampal expression of the mTOR scaffold protein Raptor. Furthermore, the anxiogenic dose of URB597 decreased the absolute number of migrating doublecortin (DCX)-positive cells in the dentate gyrus, suggesting an anti-anxiety effect independent of newly generated/immature neurons. Therefore, our results indicate that in mice exposed to repeated psychosocial stress, URB597 fails to counteract the anxiogenic-like response induced by the pharmacological dampening of mTOR signaling.


Subject(s)
Anti-Anxiety Agents , Mice , Male , Animals , Anti-Anxiety Agents/pharmacology , Sirolimus , Mice, Inbred C57BL , Endocannabinoids/pharmacology , TOR Serine-Threonine Kinases , Amidohydrolases , Receptor, Cannabinoid, CB1
2.
Cell Tissue Res ; 354(1): 119-25, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23584609

ABSTRACT

Panic disorder (PD) is a subtype of anxiety disorder in which the core phenomenon is the spontaneous occurrence of panic attacks. Although studies with laboratory animals have been instrumental for the understanding of its neurobiology and treatment, few review articles have focused on the validity of the currently used animal models for studying this psychopathology. Therefore, the aim of the present paper is to discuss the strengths and limits of these models in terms of face, construct and predictive validity. Based on the hypothesis that panic attacks are related to defensive responses elicited by proximal threat, most animal models measure the escape responses induced by specific stimuli. Some apply electrical or chemical stimulation to brain regions proposed to modulate fear and panic responses, such as the dorsal periaqueductal grey or the medial hypothalamus. Other models focus on the behavioural consequences caused by the exposure of rodents to ultrasound or natural predators. Finally, the elevated T-maze associates a one-way escape response from an open arm with panic attacks. Despite some limitations, animal models are essential for a better understanding of the neurobiology and pharmacology of PD and for discovering more effective treatments.


Subject(s)
Disease Models, Animal , Panic Disorder , Animals , Humans , Rodentia
3.
Rev Esp Cardiol ; 63(11): 1367-70, 2010 Nov.
Article in English, Spanish | MEDLINE | ID: mdl-21070732

ABSTRACT

In PHACE syndrome, the acronym PHACE stands for the association of posterior fossa malformations, cervicofacial hemangiomas, arterial anomalies, coarctation and eye anomalies. We report our findings in four patients with this syndrome, in whom it was characterized by complex aortic coarctation that required not only preoperative echocardiographic investigation, but also the use of techniques such as magnetic resonance imaging and angiography. Surgical treatment was also complex. Prognosis in this condition depends primarily on cardiovascular and cerebral artery complications associated with the syndrome.


Subject(s)
Aortic Coarctation/etiology , Aortic Coarctation/complications , Aortic Coarctation/diagnosis , Eye Abnormalities/complications , Eye Abnormalities/diagnosis , Female , Humans , Infant , Infant, Newborn , Male , Neurocutaneous Syndromes/complications , Neurocutaneous Syndromes/diagnosis , Retrospective Studies
4.
Rev. esp. cardiol. (Ed. impr.) ; 63(11): 1367-1370, nov. 2010. tab, ilus
Article in Spanish | IBECS | ID: ibc-82366

ABSTRACT

La asociación de malformaciones de la fosa posterior, hemangiomas cervicofaciales y vasculares, coartación y alteraciones oculares es conocida con el acrónimo PHACE. Presentamos un análisis de 4 casos de este síndrome, caracterizados por coartación aórtica compleja que necesita no sólo estudio ecocardiográfico preoperatorio, sino además técnicas como resonancia magnética y angiografía. El tratamiento quirúrgico es también complejo. El pronóstico está dado por las complicaciones cardiovasculares y arteriales cerebrales propias del síndrome (AU)


In PHACE syndrome, the acronym PHACE stands for the association of posterior fossa malformations, cervicofacial hemangiomas, arterial anomalies, coarctation and eye anomalies. We report our findings in four patients with this syndrome, in whom it was characterized by complex aortic coarctation that required not only preoperative echocardiographic investigation, but also the use of techniques such as magnetic resonance imaging and angiography. Surgical treatment was also complex. Prognosis in this condition depends primarily on cardiovascular and cerebral artery complications associated with the syndrome (AU)


Subject(s)
Humans , Male , Female , Infant , Aortic Coarctation/complications , Aortic Coarctation/genetics , Aortic Coarctation/therapy , Prognosis , Hemangioma/complications , Hemangioma/diagnosis , Heart Failure/congenital , Heart Failure/complications , Aortic Coarctation/physiopathology , Magnetic Resonance Imaging/methods , Retrospective Studies , Signs and Symptoms , Aorta, Thoracic/abnormalities , Aorta/abnormalities
SELECTION OF CITATIONS
SEARCH DETAIL
...